Trial intelligence / Profile preview

Permacol Paste for Cryptoglandular Anorectal Fistulas

NCT02686580Phase 3Terminated

Sponsor: Royal Devon University Healthcare NHS Foundation Trust
Start: Feb 2016
Primary completion: Oct 2018

Overview

Phase 3, open-label, single-arm trial, sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoints: Fistula Healing rate at 3 months and Fistula Healing Rate at 12 months. Started Feb 2016; status: terminated.

Beyond the preview

Go deeper on NCT02686580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02686580.